What question did this study set out to answer?

The aim is to develop a new accelerated failure time model that effectively analyzes long-term survival data with a cure fraction.

An Accelerated Failure Time Non-Mixture Cure Model for Long-Term Survival Data with Application to Brain Cancer

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial reveals improved survival modeling in brain cancer patients, suggesting better clinical insights.

The aim is to develop a new accelerated failure time model that effectively analyzes long-term survival data with a cure fraction.
Introduced an accelerated failure time non-mixture cure model using a Beta–Marshall–Olkin Extended Log-Logistic distribution.
Model estimation performed through maximum likelihood methods.
Performance evaluated with brain cancer patient data comparing against generalized gamma and generalized F distributions.
The proposed model achieved a competitive overall fit and stable parameter estimation.
Improved representation of tail behavior in the survival function was observed.
Results indicate potential for enhanced inference and decision-making in clinical research.

Huma et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark